Michael Murphy, Chief Medical and Scientific Officer at Worldwide Clinical Trials, was presented with the Clinical Research and Excellence (CARE) 2017 Lifetime Achievement Award on Wednesday, April 5, at an awards dinner in Boston, Massachusetts.
Since Worldwide was originally established as a global contract research organisation (CRO) in 1995, Murphy has worked to build the company into an industry leader, crafting the company’s consultative approach for the execution, analysis and interpretation of clinical trials.
The judges said: “Dr Murphy's personal contribution across the industry – especially in the US – combined with his efforts to educate and mentor others, make him the ideal recipient of this year’s award.”
“A true expert in the field, Dr Murphy possesses a combination of medical ability and operational acumen as well as the appreciation for the complexities of running clinical trials, which allows him to facilitate studies of life-changing medicines around the world.”
“He delivers exceptional service to clients and ensures that every drug development programme receives personal consideration and dedication.”
“I cannot imagine someone more deserving of the CARE Lifetime Achievement Award than Dr Murphy,” said Neal Cutler, CEO at Worldwide.
“His generosity of knowledge, depth of expertise and commitment to the science and medicine of clinical research has had a tremendous impact on Worldwide, its people, and our sponsors, as well as the entire industry.”
“Dr Murphy’s passion, incredible work ethic and unwavering commitment inspires all of us who work with him each and every day,” added Peter Benton, President and COO at Worldwide. “It’s our pleasure to congratulate him on behalf of the entire Worldwide family.”
Dr Murphy to dateWith a career spanning more than 25 years, Murphy’s work has emphasised the integration of medical and scientific ingenuity with operational excellence.
He is board-certified in psychiatry and has a doctorate in pharmacology, with training at Tulane University, Stanford University and the Mount Sinai School of Medicine.
He has been a consultant for the Duke Clinical Research Institute and is Founder and Research and Development Editor for American Health and Drug Benefits.
As a lecturer within the Center for Experimental Pharmacology and Therapeutics, Harvard-MIT Division of Health Sciences and Technology for 17 years, Murphy contributed to the curriculum for a two-year Clinical Investigator Training Program.
He is also a widely published author across many of the medical world’s most esteemed journals.
In recognition of Murphy’s influence and expertise, Worldwide recently created the Michael Murphy Clinical Research Methodology Fellowship Program, which offers hands-on clinical research experience for scientists who work alongside Murphy and other Worldwide experts.
The programme is intended to prepare the Fellows to support the increasingly complex clinical trials of tomorrow.
